VOLITIONRX LTD ·

VNRX 8-K 2026-09-25

VOLITIONRX LTD (VNRX) 8-K dated 2026-09-25 — accession 0001477932-26-005804. This URL is the filing, not the VNRX hub.

VOLITIONRX LTD (VNRX) is a medical devices company listed on AMEX.

VOLITIONRX LTD filed a 8-K on 2026-09-25. Accession 0001477932-26-005804.

Cached items: 3.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported VNRX revenue for 2025-12-31 was $1.7M. Net income was -$23.4M. Revenue was up 40.0% from 2024-12-31 to 2025-12-31. VNRX currently screens at market cap $15.9M.

Not investment advice. The VNRX SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR

Lician Pro $19.99/mo or $149/yr